Alzheimer's Disease Trial, Recruiting NCT05322343 Sponsor: University Hospital, Bordeaux Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05322343
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Main study:

  • People who live in the Bordeaux metropolitan area
  • People who are between 55 and 80 years old (inclusive)
  • People who fall within certain age groups and income levels that reflect the general population in that age range (confirm with trial site for details on how this is assessed)
  • People who are enrolled in the French social security system
  • People who agree to provide a blood sample for storage in a research biobank

MRI sub-study (in addition to the above):

  • People who are between 55 and 75 years old (inclusive)

Immune response sub-study:

  • People who are 70 years of age or older, or who are already participating in the MRI sub-study, and who agree to provide an additional blood sample for this part of the research

Who may not be able to join:

Main study:

  • People who are under legal guardianship or any other form of legal protection, or who are unable to give their own consent to participate

MRI sub-study:

  • People who have a pacemaker, an artificial heart valve, or any other internal electrical or magnetic medical device
  • People who have had brain surgery or have been treated for a brain aneurysm
  • People who experience claustrophobia (fear of enclosed spaces)
  • People who have metal fragments in their eyes, brain, or spinal cord

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cécilia SAMIERI, Dr, Bordeaux Population Health Researh Center Inserm

Phone: 5 57 57 45 15

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 March 2022
Est. completion
22 March 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Number of participants for whom samples are available in the biobank and nutritional and cognitive surveys have been completed.; Number of participants for whom samples are available in the biobank and nutritional and cognitive surveys have been completed.; Number of participants for whom samples are available in the biobank and nutritional and cognitive surveys have been completed.; Number of participants for whom samples are available in the biobank and nutritional and cognitive surveys have been completed.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov